67 related articles for article (PubMed ID: 33590401)
1. Investigation of the risk factors in the development of radionecrosis in patients with brain metastases undergoing stereotactic radiotherapy.
Doğan B; Demir H; Işık N; Gunalp G; Günbey HP; Yaprak G
Br J Radiol; 2024 May; 97(1157):1022-1028. PubMed ID: 38426391
[TBL] [Abstract][Full Text] [Related]
2. Survival Benefit of Stereotactic Radiotherapy in the Complex Management of Metastatic Melanoma.
Kelemen G; Együd Z; Dobi Á; Varga L; Kószó R; Borzási E; Paczona V; Végváry Z; Borzák F; Fodor E; Ócsai H; Baltás E; Oláh J; Hideghéty K
Anticancer Res; 2024 Jan; 44(1):205-212. PubMed ID: 38159978
[TBL] [Abstract][Full Text] [Related]
3. Bevacizumab reduces peritumoral brain edema in lung cancer brain metastases after radiotherapy.
Hua YC; Gao DZ; Wang KY; Ding XS; Xu WR; Li YB; Shi WW; Sun SB; Li XY
Thorac Cancer; 2023 Nov; 14(31):3133-3139. PubMed ID: 37718465
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative or postoperative stereotactic radiotherapy for brain metastases: time to systemic treatment onset and other patient-relevant outcomes.
Dejonckheere CS; Layer JP; Hamed M; Layer K; Glasmacher A; Friker LL; Potthoff AL; Zeyen T; Scafa D; Koch D; Garbe S; Holz JA; Kugel F; Grimmer M; Schmeel FC; Gielen GH; Forstbauer H; Vatter H; Herrlinger U; Giordano FA; Schneider M; Schmeel LC; Sarria GR
J Neurooncol; 2023 Sep; 164(3):683-691. PubMed ID: 37812290
[TBL] [Abstract][Full Text] [Related]
5. Overall Survival after Radiotherapy for Brain Metastases According to ECOG Status-A Prospective Study of 294 NSCLC Patients.
Karlsson AT; Hjermstad MJ; Aass N; Skovlund E; Kaasa S; Yri OE
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672568
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Results of Stereotactic Radiotherapy in Patients with at Least 10 Brain Metastases at Diagnosis.
Kinj R; Hottinger AF; Böhlen TT; Ozsahin M; Vallet V; Dunet V; Bouchaab H; Peters S; Tuleasca C; Bourhis J; Schiappacasse L
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730695
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases.
Alhalabi O; Soomro Z; Sun R; Hasanov E; Albittar A; Tripathy D; Valero V; Ibrahim NK
NPJ Breast Cancer; 2021 Mar; 7(1):28. PubMed ID: 33742001
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of salvage radiation for recurrent world health organization grade II meningiomas: a retrospective cohort study.
Momin AA; Shao J; Soni P; Almeida JP; Suh JH; Murphy ES; Chao ST; Angelov L; Mohammadi AM; Barnett GH; Recinos PF; Kshettry VR
J Neurooncol; 2021 Apr; 152(2):373-382. PubMed ID: 33590402
[TBL] [Abstract][Full Text] [Related]
9. Radiosurgery/stereotactic external beam radiotherapy for malignant brain tumours: the Royal Marsden Hospital experience.
Brada M; Laing R
Recent Results Cancer Res; 1994; 135():91-104. PubMed ID: 7519356
[TBL] [Abstract][Full Text] [Related]
10. The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review.
Lancellotta V; Del Regno L; Di Stefani A; Fionda B; Marazzi F; Rossi E; Balducci M; Pampena R; Morganti AG; Mangoni M; Lebbe C; Garbe C; Longo C; Schinzari G; Tagliaferri L; Peris K
Radiol Med; 2022 Jul; 127(7):773-783. PubMed ID: 35606609
[TBL] [Abstract][Full Text] [Related]
11. Poor performance status and brain metastases treatment: who may benefit from the stereotactic radiotherapy?
Holub K; Louvel G
J Neurooncol; 2021 Apr; 152(2):383-393. PubMed ID: 33590401
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of salvage stereotactic radiotherapy (SRT) for locally recurrent brain metastases after initial SRT and characteristics of target population.
Holub K; Louvel G
Clin Transl Oncol; 2021 Jul; 23(7):1463-1473. PubMed ID: 33464481
[TBL] [Abstract][Full Text] [Related]
13. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
[TBL] [Abstract][Full Text] [Related]
14. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of X-ray stereotactic radiotherapy on brain metastases and prognostic analysis.
Wei W; Deng ML; Wu SX; Zeng ZF; Li FY; Wang HY; Bao Y; Gao YH; Chen LX
Chin J Cancer; 2010 Feb; 29(2):202-6. PubMed ID: 20109352
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
